Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RELUGOLIX vs REMDESIVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RELUGOLIX vs REMDESIVIR: Safety Overview

Metric RELUGOLIX REMDESIVIR
Total FAERS Reports 20,660 10,501
Deaths Reported 958 2,729
Death Rate 4.6% 26.0%
Hospitalizations 1,699 2,556
Average Patient Age 72.4 yrs 61.7 yrs
% Female Patients 1.4% 39.8%
FDA Approval Date Dec 18, 2020 Oct 22, 2020
Manufacturer Sumitomo Pharma America, Inc. Gilead Sciences, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription